BLB-logo-negativo
Twitter
We are a contract research organization
Offering cutting-edge research services and consultancy in the field of liver diseases
We provide tailored reliable solutions to our partners for successful strategic decision making
Previous
Next

The complete pre-clinical Solution

Our services

BLB is a contract research organization that offers cutting-edge research services
and consultancy in the field of liver diseases.

We provide tailored reliable solutions to our partners for successful
strategic decision making

EXOLIVER®

BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
MORE INFO

TISSUES

BLB gives you the possibility to analyze your favourite gene or protein in liver tissue obtained from rodents and humans
MORE INFO

ORGAN
ON A CHIP

BLB offers high-quality services to create tailored organ on a chip platforms for preclinical human disease modelling
MORE INFO

RODENT
MODELS

BLB provides research services using topquality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
MORE INFO

PCLS

Screen your compounds in fresh precision-cut liver slices
MORE INFO

LIVER
CELLS

BLB develops analysis with highly pure and viable rodent and human primary liver cells
MORE INFO

STRATEGIC
CONSULTANCY

The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research
MORE INFO

News

Barcelona Liver Bioservices will be present at the ILC-EASL 2019

Barcelona Liver Bioservices (BLB), CRO especially focused on the field of Hepatology, announced today its participation in the upcoming International Liver Congress (ILC) 2019 – the annual meeting of the European Association for the Study of the Liver (EASL) that will take place in Vienna in April 10-14th 2019.

13/03/2019

Barcelona Liver Bioservices announces collaboration with Inventiva

Barcelona Liver Bioservices, CRO specialized in the design and development of pre-clinical studies in hepatology, announced today a non-exclusive collaboration with Inventiva, a clinical stage biopharmaceutical company with expertise in fibrosis, oncology and orphan diseases.

30/10/2018

Our partners

Proudly supported by partners and collaborators as

GAT Therapeutics
inventivapharma
readycell
brudy
gilead
conatus
caixa
idibaps

BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.

BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers

If you are interested in joining the company that is changing the pre-clinical research in the fields of hepatology and toxicology, please contact us